---

History Taking in Chronic Lung Diseases

---

1. Presenting Complaint (Chief Complaint)

---

2. History of Presenting Illness (HPI)

Dyspnea (Breathlessness)

• Onset and duration: Gradual over years (COPD, ILD, pulmonary fibrosis) vs. episodic (asthma) vs. sudden (pneumothorax)
• Progression: Slowly progressive (COPD, IPF) vs. relapsing-remitting (asthma)
• Functional impact: Grade using MRC Dyspnea Scale (Grade 1-5)
  • Grade 1: Only on strenuous exercise
  • Grade 2: Walking briskly on level ground or up a hill
  • Grade 3: Slower than others on level ground; stops on flat after 100m
  • Grade 4: Stops after a few minutes walking on flat
  • Grade 5: Too breathless to leave house; breathless at rest
• Positional: Orthopnea (heart failure, diaphragm paralysis), platypnea (hepatopulmonary syndrome)
• Exacerbating/relieving factors: Exercise, cold air, allergens, lying flat

Cough

• Duration (chronic = >8 weeks in adults)
• Character: Dry/non-productive (ILD, asthma, ACE inhibitors) vs. productive (COPD, bronchiectasis)
• Timing: Morning predominance (COPD with sputum); nocturnal (asthma, post-nasal drip, GERD)
• Haemoptysis: Amount, frequency - suggests bronchiectasis, malignancy, TB, vasculitis

Sputum

• Daily volume (bronchiectasis can produce >30 mL/day)
• Color: Clear/white (asthma, viral), yellow/green (infection - COPD exacerbation), rust-colored (pneumococcal pneumonia), pink frothy (pulmonary edema)
• Purulence: A key marker in COPD exacerbations - increased purulence + increased dyspnea + increased volume = Anthonisen Type 1 exacerbation

Wheeze

• Is it truly wheeze vs. stridor (inspiratory upper airway)?
• Episodic and reversible (asthma) vs. persistent (fixed obstruction, COPD)

Chest Pain

• Pleuritic (sharp, worse on inspiration - pleuritis, PE, pneumonia)
• Central chest tightness (asthma, cardiac)

---

3. Smoking History - MANDATORY

• Smoking status: Current / ex-smoker / never-smoker
• Pack-year history: (cigarettes/day ÷ 20) × years smoked
  • e.g., 20/day for 30 years = 30 pack-years
• Type: Cigarettes, cigars, pipe, cannabis, e-cigarettes, hookah (shisha)
• Age started, age stopped (if ex-smoker), reason for stopping
• Passive smoke exposure: At home or workplace
• COPD is uncommon with <10 pack-years; consider alternative diagnoses in never-smokers

---

4. Occupational and Environmental Exposure History

Key occupations and associated lung diseases:

• "Have you ever worked in any dusty, chemical, or fume-heavy environment?"
• "Have your symptoms improved on weekends or holidays?" (strongly suggests occupational asthma)
• "What is the interval between exposure and onset of symptoms?"
• Indoor environment: molds, damp walls, air conditioning filters, pets (birds especially)

---

5. Drug and Medication History

• Amiodarone - pulmonary fibrosis (one of the most common)
• Methotrexate - hypersensitivity pneumonitis
• Bleomycin - fibrosing alveolitis
• Nitrofurantoin - acute and chronic pulmonary reactions
• ACE inhibitors - chronic dry cough (in up to 15% of users)
• Beta-blockers - can worsen bronchospasm in asthma/COPD
• NSAIDs, aspirin - exacerbate asthma in NSAID-sensitive patients
• Illicit drugs: Cocaine (pulmonary hemorrhage), heroin, cannabis
• Over-the-counter supplements, herbal remedies (often overlooked)

---

6. Past Medical History

• Prior respiratory illnesses: childhood asthma, recurrent chest infections, TB, pertussis
• Hospitalizations for chest disease - particularly ICU admissions or intubations (indicates severity)
• Previous pulmonary function tests (spirometry results, trend over time)
• Previous chest X-rays or CT scans
• History of allergies or atopy (eczema, allergic rhinitis, food allergies) - atopic triad suggests asthma
• Connective tissue diseases (RA, SLE, systemic sclerosis, polymyositis) - all can cause ILD
• GERD (can trigger asthma and cough)
• Recurrent sinusitis (granulomatosis with polyangiitis, Kartagener's)
• Immunosuppression (HIV, transplant, long-term steroids) - consider opportunistic infections

---

7. Family History

• Asthma or atopy in first-degree relatives (strong genetic component)
• Alpha-1 antitrypsin deficiency (autosomal co-dominant) - suspect in early-onset COPD, non-smokers, or lower lobe emphysema
• Cystic fibrosis (autosomal recessive) - bronchiectasis in young adults
• Familial IPF (rare but recognized)
• Pulmonary arterial hypertension (BMPR2 mutations)

---

8. Social History

• Alcohol: Can cause aspiration pneumonia, risk for TB
• Housing: Damp, mould exposure; housing type (inner city vs. rural)
• Pets: Birds (HP), cats, dogs (allergens)
• Travel: TB endemic areas, histoplasmosis/coccidioidomycosis (endemic mycoses)
• Hobbies: Pigeon racing, mushroom growing, hot tub use
• Exercise capacity: Specifically, what activities are now limited that were not before? (functional decline)
• Nutrition: Weight loss suggests malignancy, advanced COPD, or systemic disease

---

9. Systems Review Relevant to Chronic Lung Disease

---

10. Specific Points for Common Chronic Lung Diseases

COPD

• Smoking history (almost always present; >10 pack-years)
• Onset of symptoms: typically after age 40
• Chronic productive cough, especially in morning (chronic bronchitis component)
• Exercise-limiting dyspnea, progressive
• Exacerbation history: frequency per year, what triggers them, hospital admissions
• Ask about "blue bloater" vs. "pink puffer" features historically

Asthma

• Episodic wheeze and breathlessness - diurnal variation (worse at night/early morning)
• Identifiable triggers: allergens, exercise, cold air, NSAIDs, aspirin, stress
• Symptom-free intervals between attacks
• Personal/family history of atopy
• Response to bronchodilators
• Seasonal variation

Bronchiectasis

• Chronic productive cough - large volumes of sputum, often purulent
• Postural drainage (sputum production increases on lying down)
• Recurrent chest infections requiring antibiotics
• Underlying cause: childhood infections, TB, immune deficiency, cystic fibrosis, PCD

Interstitial Lung Disease / IPF

• Insidious onset, usually >50 years
• Dry, non-productive cough
• Progressive exertional dyspnea
• No identifiable trigger in IPF; extensive exposure history critical for secondary ILD
• Duration >4 weeks distinguishes from acute HP or infection
• Symptoms <4 weeks with fever suggest cryptogenic organizing pneumonia, acute HP, or drug reaction

Pulmonary Hypertension

• Progressive exertional dyspnea as earliest symptom
• Syncope or pre-syncope on exertion (a red flag)
• Ankle edema, fatigue
• Features of underlying cause: CTD, HIV, portal hypertension, chronic PE

---

Summary: The Structured Approach

CHRONIC LUNG DISEASE HISTORY - CHECKLIST
==========================================
1. Chief complaint + characterize each symptom (SOCRATES approach)
2. Dyspnea: onset, progression, MRC grade, functional impact
3. Cough: duration, character, haemoptysis
4. Sputum: volume, colour, purulence
5. Wheeze/chest tightness: pattern, triggers
6. SMOKING: pack-year history (MANDATORY)
7. Occupational/environmental history: lifelong, latency noted
8. Drug history: amiodarone, MTX, bleomycin, ACE-i, beta-blockers
9. Past medical history: childhood illness, hospitalisations, PFTs
10. Family history: atopy, AAT deficiency, CF
11. Social history: housing, pets, travel, hobbies
12. Systems review: extrapulmonary clues to systemic disease

---

• Goldman-Cecil Medicine - Chapter 80: Interstitial Lung Disease (History section)
• Fishman's Pulmonary Diseases and Disorders, 2-Volume Set - COPD pathophysiology
• Goldman-Cecil Medicine, Chapter 80, p. 936 - ILD diagnostic approach

---

PSM Question Paper - Complete Answers

• Q1 & Q2: Long Essays (~10 marks each)
• Q3-Q10: Short Essays (~5 marks each)
• Q11-Q20: Short Answers (~2-3 marks each)

---

LONG ESSAYS

---

Q1. IMNCI: Rationale, Six Elements, Application in 3-Year-Old with Cough/Difficulty in Breathing (10 Marks)

Part A: Rationale for IMNCI

• Pneumonia, diarrhea, malaria, measles, and malnutrition account for ~70% of all under-5 deaths
• Children often present with multiple, overlapping illnesses - a single-disease approach is inadequate
• Most deaths occur at home or in primary health facilities with limited diagnostic equipment
• IMNCI provides a simple, systematic clinical assessment tool usable by health workers at all levels
• It promotes rational drug use, appropriate referral, and parental counseling
• India adopted IMNCI as part of RMNCH+A strategy under NHM

Part B: Six Elements of IMNCI Case Management Process

Part C: Application in a 3-Year-Old with Cough/Difficulty in Breathing

• Duration of cough (>2 weeks = suspect TB/chronic cause)
• Count respiratory rate: ≥40 breaths/min = fast breathing (pneumonia)
• Look for chest indrawing (severe pneumonia)
• Check for stridor when calm
• Check for general danger signs:
  • Unable to drink/breastfeed
  • Vomits everything
  • Convulsions
  • Lethargic/unconscious

• For PNEUMONIA: Amoxicillin 40 mg/kg/day in 2 divided doses × 5 days
• For SEVERE PNEUMONIA: First-dose ampicillin + gentamicin before referral

• Administer first dose of appropriate antibiotic
• Treat fever if present (paracetamol)
• Ensure child can swallow medicine

• Continue feeding; extra fluids
• Signs of worsening: breathing becomes very difficult, child cannot drink
• Complete full course of antibiotics
• Return immediately if fast breathing worsens or chest indrawing develops

• Return after 2 days if on oral amoxicillin
• Assess: Is breathing better? Is chest indrawing gone? Is child eating well?

---

Q2. Occupational Diseases Due to Physical Agents: Classification, Examples, Prevention (10 Marks)

Part A: Classification of Occupational Diseases Due to Physical Agents

Part B: Prevention of Occupational Diseases

• Engineering controls (most effective - hierarchy of control):
  • Substitution of hazardous process
  • Enclosure/isolation of noise sources
  • Sound-absorbing materials in walls and ceilings
  • Use of vibration-damping materials
  • Adequate ventilation and air conditioning for heat
• Administrative controls:
  • Job rotation to reduce duration of exposure
  • Limiting working hours (Factories Act limits)
  • Adequate rest periods in hot environments
  • Pre-employment medical examination - exclude susceptible individuals
• Personal Protective Equipment (PPE):
  • Ear muffs/ear plugs for noise (last resort)
  • Protective clothing for cold/heat/radiation
  • Lead aprons for ionizing radiation
  • Anti-vibration gloves for HAVS

• Periodic medical examinations / surveillance audiometry
• Biological monitoring (blood lead levels, etc.)
• Pre-placement and annual health checks
• Prompt treatment and removal from exposure on early signs

• Vocational rehabilitation
• Compensation under Workmen's Compensation Act / ESI Act
• Hearing aids for NIHL
• Reassignment to non-hazardous work

• Factories Act 1948 - maximum permissible noise levels (90 dB for 8 hrs)
• Atomic Energy Act for radiation protection
• Mines Act for mining hazards

---

SHORT ESSAYS

---

Q3. Causes of Juvenile Delinquency in India and Preventive Measures (5 Marks)

1. Social maladjustment - inability to adapt to social norms
2. Poverty - economic deprivation driving theft, begging, crime
3. Disturbed home conditions - broken families, parental conflict, neglect
4. Alcoholism and drug addiction in family members
5. Modern lifestyle influences - social media, internet, peer pressure
6. Lack of educational opportunity and school dropout
7. Child labor - exploitation leading to antisocial behavior
8. Urbanization - migration to cities without family support
9. Neighbourhood environment - living in slums/high-crime areas
10. Mental health issues - undiagnosed behavioral disorders

• Legislative: The Children Act 1960 - specialized courts (Juvenile Courts), Child Welfare Boards, Remand Homes, Certified Schools, After-care facilities; Juvenile Justice Act 2015 (amended)
• Educational: Universal primary education, vocational training, mid-day meal scheme to retain children in school
• Family support: Counseling services for dysfunctional families, poverty alleviation programs
• Community: Recreation facilities, youth clubs, sports programs
• Health services: Mental health care, de-addiction services for youth
• Media regulation: Control of violent/antisocial content

---

Q4. Disease Prevention at Various Levels Among the Elderly in India (5 Marks)

• Vaccination: Influenza, pneumococcal, COVID-19, herpes zoster vaccines
• Balanced diet - adequate calcium, protein, vitamins D & B12
• Regular physical activity - 150 min/week moderate activity to prevent falls, osteoporosis
• Cessation of smoking/alcohol
• Control of hypertension and diabetes at community level
• Mental health promotion - social engagement, intellectual activity
• National Programme for Health Care of Elderly (NPHCE) - health promotion

• Screening programs: Blood pressure, blood glucose, lipid profile
• Vision and hearing screening
• Cancer screening: Cervical smear, breast exam, colorectal screening
• Cognitive screening for dementia (MMSE)
• Bone density (DEXA) for osteoporosis
• Geriatric assessment clinics at PHC level under NPHCE

• Rehabilitation for stroke, hip fracture, joint replacement
• Long-term care for bedridden elderly
• Palliative care services
• Social support: Old age homes, day care centers, helplines (Elder Line 14567 in India)
• Geriatric wards at district hospitals

---

Q5. Adolescent Reproductive and Sexual Health (ARSH) Programme (5 Marks)

• Nutrition
• Sexual and Reproductive Health (SRH)
• Non-communicable diseases
• Mental health
• Substance misuse
• Injuries and violence (including gender-based violence)

• Weekly Iron Folic Acid Supplementation (WIFS) - every Monday for adolescent girls and boys in schools
• Biannual deworming (Albendazole)
• Adolescent-friendly health clinics (AFHCs) at CHC level - confidential, non-judgmental
• Peer educators (trained adolescents) for IEC
• Counseling on menstruation, contraception, STIs, HIV, early marriage

• Education on safe sex, contraception, STI prevention
• HIV/AIDS awareness
• Counseling on early marriage (PCMA Act - 18 for girls, 21 for boys)
• Services for adolescent pregnancy
• RTI/STI management

---

Q6. Any Four Side Effects of IUCD (5 Marks)

• Increased menstrual blood loss (menorrhagia) - up to 50% more bleeding
• Dysmenorrhoea (painful periods) - increased prostaglandin release due to copper
• Intermenstrual spotting/metrorrhagia
• Can lead to iron-deficiency anaemia if prolonged

• Pelvic cramping especially in first few months after insertion
• Backache
• Pain during insertion (especially in nulliparous women)

• Risk highest in first 20 days after insertion (insertion-related)
• Endometritis, salpingitis
• Risk increased with multiple sexual partners (STI-associated)
• Can lead to infertility if untreated

• Spontaneous expulsion rate: 5-10% in first year
• Higher risk in: young nulliparous women, immediately post-partum insertion
• Silent expulsion - woman may not notice, leading to unwanted pregnancy

• Ectopic pregnancy (if IUCD fails, ectopic more likely)
• Uterine perforation at insertion (rare: 1 in 1000)
• Missing threads (thread retraction)

---

Q7. MTP Act 1971 - Conditions, Persons, and Settings (5 Marks)

Conditions Under Which Pregnancy Can Be Terminated (5 conditions):

1. Medical - Continuation of pregnancy would endanger the mother's life or cause grave injury to her physical or mental health (including mental health resulting from pregnancy)
2. Eugenic - Substantial risk that child would be born with serious physical or mental abnormalities (handicaps)
3. Humanitarian - Pregnancy is the result of rape (rape of a woman)
4. Socio-economic - Actual or reasonably foreseeable social or economic conditions likely to cause risk to mother's health
5. Failure of contraception - Anguish caused by unwanted pregnancy from failure of contraceptive device is presumed to constitute grave mental injury (unique to Indian law - virtually allows abortion on request)

Persons Who Can Perform MTP:

• Up to 12 weeks: A single Registered Medical Practitioner (RMP) with training/experience in obstetrics and gynaecology
• 12-20 weeks: Opinion of TWO Registered Medical Practitioners required
• MTP (Amendment) Act 2021: Extended upper limit to 24 weeks for special categories (rape survivors, minors, differently-abled women, fetal abnormalities)

Settings Where MTP Can Be Done:

• Government hospital established/maintained by Government, OR
• A place approved for the purpose by the Government
• Abortion must be kept strictly confidential

---

Q8. Indices to Assess Protein Quality and Quantity; Why Egg Protein is Reference Protein (5 Marks)

Indices to Assess Protein Quality:

• Proportion of absorbed nitrogen that is retained by the body
• BV = (Nitrogen retained / Nitrogen absorbed) × 100
• Egg = BV 100 (reference), Milk = 85, Meat = 75, Wheat = 65

• Proportion of dietary nitrogen that is retained
• NPU = BV × Digestibility coefficient
• Accounts for both quality AND digestibility
• NPU = (Nitrogen retained / Nitrogen intake) × 100

• Weight gain per gram of protein consumed in growing rats
• PER = Weight gain (g) / Protein intake (g)
• Standard: Casein PER = 2.5

• Compares limiting essential amino acid of test protein against reference protein
• Chemical score = (mg of limiting AA in 1g test protein / mg same AA in 1g reference protein) × 100
• PDCAAS (Protein Digestibility Corrected Amino Acid Score) = currently recommended by FAO/WHO

• True digestibility = % of ingested protein actually absorbed

• Currently the preferred method for measuring protein quality

Why Egg Protein is the Reference Protein:

• Egg white (albumin) contains ALL essential amino acids in the exact proportions required by the human body
• Biological Value = 100 (highest possible; it means 100% of absorbed egg protein nitrogen is retained)
• Highly digestible (digestibility coefficient ~97%)
• Contains no anti-nutritional factors (unlike plant proteins: phytates, tannins, trypsin inhibitors)
• When other proteins are compared, their limiting amino acid is identified against egg's amino acid profile
• This is why egg protein is assigned a chemical score of 100 and used as the "gold standard" reference

---

Q9. Health Programme Promotive Measures for Prevention of PEM (5 Marks)

---

Q10. Pasteurization of Milk and Methods (5 Marks)

• Destroys pathogenic bacteria: Mycobacterium tuberculosis (most heat-resistant non-sporing pathogen - index organism), Salmonella, Brucella, Streptococcus, Listeria, Campylobacter
• Does NOT sterilize (does not kill spores or all organisms)
• Extends shelf life
• Does not significantly alter nutritional value

• Phosphatase Test - Phosphatase enzyme is destroyed at pasteurization temperatures; its absence confirms adequate pasteurization
• Negative phosphatase = adequately pasteurized
• Methylene Blue Reduction Test (MBRT) - assesses bacteriological quality

---

SHORT ANSWERS

---

Q11. Dietary Principles of a Prudent Diet (2-3 Marks)

1. Variety - eat foods from all food groups; no single food is complete
2. Calorie control - balance energy intake with expenditure; avoid obesity
3. Reduce saturated and trans fats - <10% of total calories from saturated fat; avoid trans fats; use unsaturated fats (MUFA/PUFA)
4. Increase fibre - ≥25-30g/day; whole grains, fruits, vegetables, legumes
5. Reduce sodium - <5g salt/day (WHO); to prevent hypertension
6. Reduce added sugars - <10% of total calories; prevent diabetes/obesity
7. Adequate fruits and vegetables - ≥400g/day (5 portions); antioxidants, micronutrients
8. Limit red/processed meat - associated with colorectal cancer
9. Adequate water - 2-3 litres/day
10. Moderation in alcohol - preferably none

---

Q12. Rule of Halves (2-3 Marks)

• Of all hypertensives in a community - only HALF are diagnosed
• Of those diagnosed - only HALF are on treatment
• Of those on treatment - only HALF are adequately controlled

• Only 1/8 (12.5%) of all hypertensives actually have their blood pressure controlled
• Highlights the enormous gap between disease burden and actual management
• Applies to other NCDs: diabetes, epilepsy, mental illness

• Points to failures at detection, treatment initiation, and treatment adherence
• Guides health system strengthening - screening programs, treatment availability, adherence support

---

Q13. Epidemiological Determinants of Rheumatic Fever (2-3 Marks)

• Age: Peak 5-15 years; uncommon <3 years and >15 years
• Sex: Equal in children; females slightly more susceptible to chorea
• Genetic susceptibility: HLA-DR4, HLA-DR2 associations
• Previous RF increases risk of recurrence
• Nutritional status: Malnutrition increases susceptibility

• Overcrowding - facilitates streptococcal spread
• Poor housing and sanitation
• Cold and wet climate (increases streptococcal pharyngitis)
• Low socioeconomic status
• Seasonal variation - peaks in winter/spring (streptococcal pharyngitis season)
• Urban > rural initially; but rural prevalence high in India

• Prevalence: ~1% of school-age children
• Leading cause of acquired heart disease in children and young adults

---

Q14. PERT (2-3 Marks)

• A project management and planning tool used in health programme management
• Developed by US Navy in 1958 for Polaris missile project
• Used for planning, scheduling, and controlling complex projects

1. Network diagram (PERT Chart) - shows sequence of activities as nodes and arrows
2. Three time estimates for each activity:
   • Optimistic time (O) - best case
   • Most likely time (M) - realistic
   • Pessimistic time (P) - worst case
   • Expected time (Te) = (O + 4M + P) / 6
3. Critical Path - longest path through network = minimum project completion time
4. Slack/Float - amount of delay permissible in non-critical activities

---

Q15. Approaches in Health Education (2-3 Marks)

• One-to-one counseling (most effective for behavior change)
• Used in clinical settings, home visits

• Group discussions, lectures, demonstrations
• Suitable for school health, community groups, health talks at OPD

• Mass media: TV, radio, newspapers, social media
• Posters, pamphlets, hoardings
• Reaches large populations but limited interaction

• Direct (face-to-face) - highest impact
• Indirect (mediated) - print, electronic, digital media

• Visual: posters, films, demonstrations
• Auditory: radio, talks, songs
• Combined: TV, drama, street plays (Nukkad Natak)

---

Q16. Objectives of PNC (Postnatal Care) (2-3 Marks)

1. Prevent and detect complications in mother (PPH, puerperal sepsis, pre-eclampsia, anaemia)
2. Promote breastfeeding (initiation within 1 hour of birth; exclusive breastfeeding for 6 months)
3. Ensure immunization of the newborn (BCG, OPV-0, Hep B at birth)
4. Promote newborn care: warmth, hygiene, cord care, danger signs
5. Counsel on nutrition, iron-folic acid supplementation continuation
6. Family planning counseling and contraceptive provision
7. Detection and management of puerperal mental health issues (postnatal depression)
8. Vitamin K prophylaxis for newborn

---

Q17. Any 6 Job Responsibilities of Female Health Worker (ANM) (2-3 Marks)

1. Maternal care: Antenatal registration, ANC check-ups (BP, weight, haemoglobin, urine), TT immunization, IFA distribution
2. Delivery care: Conducting normal deliveries; identifying complications and referral
3. Postnatal care: PNC home visits at 24-48 hours, 7 days; breastfeeding promotion
4. Child health: Immunization under UIP (BCG, OPV, DPT, Measles, Hepatitis B), growth monitoring, Vitamin A supplementation
5. Family planning: Providing temporary contraceptives (oral pills, condoms, IUCD insertion), counseling on family planning, motivating couples
6. Disease surveillance and control: Reporting notifiable diseases, malaria blood smear collection, leprosy case detection, health education

---

Q18. Triage (2-3 Marks)

• START Triage (Simple Triage and Rapid Treatment) - used in mass casualty
• SALT Triage (Sort, Assess, Life-saving interventions, Treatment/Transport)
• CIAMPEDS for pediatric triage

---

Q19. Dane Particles (2-3 Marks)

• Spherical, double-shelled DNA virus, 42 nm in diameter
• Outer coat (envelope): Contains HBsAg (Hepatitis B Surface Antigen) - also known as "Australian Antigen" (discovered by Blumberg)
• Inner core: Contains HBcAg (Hepatitis B Core Antigen), HBeAg, and circular double-stranded DNA + DNA polymerase

• 20 nm spherical particles - incomplete, non-infective; excess HBsAg
• 20 nm tubular/filamentous particles - non-infective; HBsAg

• Dane particles = infective virus = marker of active viral replication
• Presence of HBeAg (from core) correlates with Dane particle count and high infectivity
• Basis for HBV serology - detecting HBsAg in blood is the standard screening test

---

Q20. WHO (World Health Organization) (2-3 Marks)

• World Health Assembly (WHA) - supreme governing body; meets annually; 194 member states
• Executive Board - 34 members; implements WHA decisions
• Secretariat - headed by Director-General

1. Setting norms and standards for health
2. Providing technical assistance to countries
3. Monitoring global health situations and trends
4. Research coordination
5. Developing and promoting health policies
6. Emergency response (outbreaks, disasters)

---

Summary of Answers Provided

Long Essays (~10 marks each)

Short Essays (~5 marks each)

Short Answers (~2-3 marks each)

---

Already Answered - Complete Solutions

Long Essays (10 marks each)

• Rationale (why IMNCI was developed - 70% under-5 deaths from 5 diseases)
• Six elements: Assess → Classify → Identify Treatment → Treat → Counsel → Follow-up
• Full application in 3-year-old with cough/breathing: respiratory rate counting, chest indrawing, danger signs, classification table (Severe Pneumonia/Pneumonia/No Pneumonia), drug doses (Amoxicillin 40 mg/kg/day), counseling points, follow-up at 2 days

• 9 categories: Noise (NIHL), Vibration (HAVS), Heat, Cold, Ionizing radiation, Non-ionizing radiation, High pressure (Caisson disease), Low pressure (altitude sickness), Electricity - each with example occupation
• Prevention: Engineering controls → Administrative controls → PPE → Secondary (screening) → Tertiary (rehabilitation) → Legislative measures (Factories Act)

---

Short Essays (5 marks each)

---

Short Answers (2-3 marks each)

---

---

PSM Complete Answers - Detailed According to Marks

• Q1 & Q2 = Long Essays = 10 marks each
• Q3 to Q10 = Short Essays = 5 marks each
• Q11 to Q20 = Short Answers = 2 marks each

---

LONG ESSAYS (10 Marks Each)

---

Q1. Rationale for IMNCI | Six Elements of IMNCI Case Management | Application in 3-Year-Old with Cough/Difficulty in Breathing (10 Marks)

---

PART A: Rationale for IMNCI (2 marks)

• A joint WHO/UNICEF strategy; adopted by India under RCH-II/NRHM
• Indian adaptation renamed from IMCI to IMNCI to include neonates (0-7 days)

1. Multiple overlapping illnesses: Most sick children present with signs of more than one illness simultaneously (diarrhoea + fever + malnutrition). A single-disease approach is inadequate
2. Burden of disease: Diarrhoea (13%), ARI (17%), fever (27%), undernutrition (43%) account for the vast majority of under-5 morbidity (NFHS-III data)
3. High under-5 mortality: Pneumonia, diarrhoea, malaria, measles, and malnutrition cause ~70% of all under-5 deaths worldwide
4. Limited diagnostic infrastructure: Primary health facilities lack equipment; IMNCI provides clinical assessment tools usable without investigations
5. Cost-effectiveness: Integrated approach is more cost-effective than disease-specific programs
6. Comprehensive: Covers preventive, promotive, and curative aspects
7. Central pillar of child health under RCH-II/NRHM; implemented at household level (by ASHA), sub-centre (ANM), and PHC level (MO, LHV)

• Inclusion of 0-7 days age group (neonates) - hence "N" in IMNCI
• Incorporates national guidelines on malaria, anaemia, Vitamin A, immunization schedule
• Training begins with sick young infants up to 2 months
• Equal proportion of training time for young infant and older child
• Skill-based training approach

---

PART B: Six Elements of IMNCI Case Management Process (3 marks)

Element 1: ASSESS

• Check for general danger signs first:
  • Unable to drink/breastfeed
  • Vomits everything
  • Convulsions (current/history)
  • Lethargic or unconscious
• Then ask about main symptoms: cough, diarrhoea, fever, ear problems
• Check nutrition and immunization status
• Look for other health problems
• Assessment uses: history, observation (respiratory rate, chest indrawing), examination

Element 2: CLASSIFY

• Use a colour-coded triage system:

• Because children often have multiple illnesses, each condition is classified separately

Element 3: IDENTIFY TREATMENT

• Based on classification, identify specific treatments
• If urgent referral needed: give pre-referral treatment (first dose antibiotics, etc.)
• If treating at home: develop an integrated treatment plan
• Give first dose of drugs in the clinic and demonstrate to caretaker
• Check if immunization is due - administer if needed

Element 4: TREAT / PROVIDE TREATMENT INSTRUCTIONS

• Administer prescribed medications
• Teach caretaker how to:
  • Give oral drugs at home
  • Feed and give fluids during illness
  • Treat local infections at home (e.g., eye drops, skin care)
• Advise on when to return immediately (danger signs)
• Schedule follow-up date

Element 5: COUNSEL THE CARETAKER

• Feeding counseling: continue breastfeeding, give extra fluids, continue feeding
• Counsel mother about her own health (nutrition, family planning)
• Check the caretaker's understanding of advice given
• Show how to administer first dose of treatment in clinic

Element 6: FOLLOW-UP CARE

• When child is brought back as requested - give follow-up care
• Reassess the child for new problems
• Check if treatment is working
• If condition has not improved or worsened - reassess and refer if needed

---

PART C: Application in a 3-Year-Old with Cough/Difficulty in Breathing (5 marks)

STEP 1 - ASSESS

• Can the child drink or breastfeed? - YES/NO
• Does the child vomit everything? - YES/NO
• Has the child had convulsions? - YES/NO
• Is the child lethargic or unconscious? - YES/NO

• Duration of cough: _____ days/weeks (>14 days = suspect TB)
• Count respiratory rate for ONE FULL MINUTE:
  • For child 12 months-5 years: Fast breathing = ≥ 40 breaths/min
• Look for chest indrawing (lower chest wall goes IN on inspiration)
• Look for stridor (harsh inspiratory noise = indicates upper airway obstruction)
• Look for central cyanosis

STEP 2 - CLASSIFY (Colour-Coded)

STEP 3 - IDENTIFY TREATMENT

STEP 4 - TREAT (in clinic)

• Administer first dose of Amoxicillin in clinic
• Demonstrate how to give tablet/syrup at home
• Give Paracetamol if temperature ≥38.5°C
• Treat ear infection if also present
• Check immunization status - give if due

• First dose Ampicillin 50 mg/kg IM + Gentamicin 7.5 mg/kg IM
• Give oxygen at 1-2 L/min via nasal prongs
• Refer with referral note
• Keep child warm on the way

STEP 5 - COUNSEL CARETAKER

• Continue feeding: breastfeed more frequently, offer extra fluids (ORS, soups, water)
• Complete full course of antibiotics (5 days) - do not stop even if child improves
• Return IMMEDIATELY if:
  • Child breathing becomes difficult
  • Child cannot drink or eat
  • Child gets worse
  • Child develops fever
  • Chest indrawing develops
• Scheduled follow-up in 2 days for Yellow (Pneumonia)

STEP 6 - FOLLOW-UP (after 2 days for PNEUMONIA)

• Is breathing better? Respiratory rate normal?
• Is chest indrawing gone?
• Is child eating and drinking well?
• Is fever gone?

---

Q2. Occupational Diseases Due to Physical Agents: Classification with Examples + Prevention Measures (10 Marks)

---

PART A: Classification of Occupational Diseases Due to Physical Agents with Examples (5 marks)

1. Noise

2. Vibration

3. Extreme Heat

4. Extreme Cold

5. Ionizing Radiation

6. Non-Ionizing Radiation

7. Elevated Atmospheric Pressure (Hyperbaric)

8. Reduced Atmospheric Pressure (Hypobaric)

9. Electricity

---

PART B: Prevention of Occupational Diseases (5 marks)

PRIMARY PREVENTION

1. Substitution: Replace hazardous process with a safer one (e.g., replace pneumatic drills with hydraulic ones)
2. Enclosure/Isolation: Enclose noise sources; isolate radiation sources with lead shielding
3. Damping: Anti-vibration mountings on machinery; vibration-absorbing handles
4. Ventilation: Exhaust ventilation to remove heat; general dilution ventilation
5. Automation: Remove workers from hazardous areas (remote-controlled machinery)
6. Acoustic materials: Sound-absorbing walls, ceilings, baffles in noisy workplaces

1. Job rotation: Limit duration of exposure per individual worker
2. Reduced working hours in hazardous conditions (Factories Act: max exposure limits)
3. Adequate rest periods: Enforced breaks in hot environments; hydration breaks
4. Pre-placement medical examination: Exclude susceptible individuals (e.g., exclude those with pre-existing SNHL from noisy work)
5. Acclimatization: Gradual increase in heat/cold exposure for new workers over 1-2 weeks
6. Training and education: Workers trained on hazard recognition, safe practices, use of PPE

SECONDARY PREVENTION

1. Periodic Medical Surveillance: Annual audiometry for noise-exposed workers; blood counts for radiation workers; lung function tests
2. Biological Monitoring: Radiation film badges (TLD - Thermoluminescent dosimeter), blood lead levels
3. Environmental Monitoring: Regular noise level measurements (decibel monitoring), radiation area surveys
4. Pre-placement examination: Establish baseline before exposure begins
5. Early removal: Remove worker from exposure at first sign of disease (noise notch at 4000 Hz)

TERTIARY PREVENTION

1. Rehabilitation: Vocational rehabilitation - reassign to less hazardous work
2. Hearing aids: For established NIHL
3. Compensation: Under Workmen's Compensation Act 1923 / Employees' State Insurance (ESI) Act 1948 - scheduled occupational diseases are compensable
4. Prosthetics and physiotherapy: For frostbite amputations, burn injuries

LEGISLATIVE MEASURES

1. Factories Act 1948: Maximum permissible noise level 90 dB(A) for 8 hr/day; heat stress provisions; safety committees
2. Atomic Energy Act 1962: Radiation protection; dose limits (20 mSv/year for workers)
3. Mines Act 1952: Specific provisions for underground miners
4. Employee State Insurance Act 1948: Medical benefits and compensation for occupational diseases
5. ILO Conventions: India has ratified conventions on occupational health and safety

---

SHORT ESSAYS (5 Marks Each)

---

Q3. Causes of Juvenile Delinquency in India + Preventive Measures (5 Marks)

Definition

Causes of Juvenile Delinquency in India (2.5 marks)

Individual Factors:

1. Mental health disorders - undiagnosed behavioural disorders (ADHD, conduct disorder)
2. Low intelligence - limited academic achievement, school dropout
3. Substance abuse - drug/alcohol use leading to antisocial acts

Family Factors:

1. Disturbed home conditions - broken families, parental conflict, domestic violence, neglect
2. Alcoholism and drug addiction among parents
3. Poverty - economic deprivation drives theft, begging, crime
4. Lack of parental supervision and guidance
5. Child abuse (physical, sexual, emotional) - trauma leading to delinquent behaviour

Social/Environmental Factors:

1. Social maladjustment - inability to adapt to social norms and expectations
2. Modern ways of living - social media, internet, influence of violent content, disco culture, peer pressure
3. Urbanization - rural-urban migration; children without family support in cities
4. Neighbourhood - living in slums, high-crime areas, negative peer group
5. Lack of educational opportunities and unemployment
6. Child labour - exploitation creates resentment and antisocial behaviours
7. Inadequate recreational facilities for youth

Preventive Measures (2.5 marks)

Legislative Measures:

• The Children Act 1960: Specialized approach for care, protection, maintenance, training and rehabilitation of delinquent children
  • Juvenile/Children's Courts
  • Child Welfare Boards
  • Remand Homes
  • Certified Schools
  • Children's Homes
  • After-care facilities
• Juvenile Justice (Care and Protection of Children) Act 2015 (amended 2021): Replaces older acts; child-friendly justice system; Juvenile Justice Boards; distinction between heinous, serious, and petty offences

Educational Measures:

• Universal primary education; prevention of school dropouts
• Mid-day meal scheme - retains children in school
• Vocational training for older adolescents
• Life skills education in schools

Family and Community Measures:

• Family counseling services for dysfunctional families
• Poverty alleviation programs (MNREGS, housing schemes)
• Recreational facilities, playgrounds, youth clubs, sports programmes
• Community surveillance and neighbourhood support groups

Health Measures:

• Mental health services for children and adolescents
• De-addiction services
• RKSK (Rashtriya Kishor Swasthya Karyakram) - addressing adolescent issues comprehensively

---

Q4. Disease Prevention at Various Levels Among the Elderly Population in India (5 Marks)

Introduction (0.5 marks)

• Elderly = persons aged 60 years and above (India)
• India has approximately 140 million elderly (12% of population); fastest growing age group
• Common diseases: Hypertension, Type 2 DM, COPD, cataracts, dementia, depression, osteoporosis, cancers, stroke, falls
• Key Programme: NPHCE (National Programme for Health Care of the Elderly) under NHM

---

Primary Prevention - Preventing Disease Before It Occurs (1.5 marks)

1. Vaccinations: Influenza (annual), Pneumococcal (PPSV23), COVID-19 booster, Herpes Zoster (Zostavax/Shingrix)
2. Nutrition: Adequate calcium (1200 mg/day) + Vitamin D (800 IU/day) to prevent osteoporosis; protein supplementation to prevent sarcopenia
3. Physical activity: Minimum 150 min/week of moderate aerobic activity + balance/strengthening exercises (prevent falls, maintain muscle mass)
4. Tobacco cessation: Reduces COPD, cardiovascular disease, lung cancer
5. Alcohol moderation: Prevents liver disease, falls, dementia, heart disease
6. Mental health promotion: Social engagement, cognitive stimulation (reading, puzzles), intergenerational contact
7. Prevention of falls: Home modifications (grab bars, non-slip mats), exercise for balance, medication review (stopping polypharmacy)
8. Control of hypertension and diabetes at community level (salt reduction, weight management)
9. NPHCE activities: Health camps, health promotion, awareness for elderly

---

Secondary Prevention - Early Detection and Treatment (1.5 marks)

1. Screening clinics for NCDs: Blood pressure, fasting blood glucose, lipid profile
2. Vision and hearing screening: Cataracts, presbycusis (hearing aids if needed)
3. Cancer screening:
   • Cervical cancer: PAP smear
   • Breast cancer: CBE, mammography
   • Colorectal cancer: Faecal occult blood test, colonoscopy
   • Oral cancer: Oral examination (high burden in India due to tobacco/betel)
4. Cognitive screening: MMSE (Mini Mental State Examination) for dementia
5. Bone density (DEXA scan): Screen for osteoporosis in post-menopausal women
6. Depression screening: GDS (Geriatric Depression Scale)
7. Under NPHCE: Dedicated geriatric OPDs at district hospitals; domiciliary visits by ASHA workers; geriatric assessment clinics at PHC level
8. RBSK extended: Health screening services for the elderly through health and wellness centres

---

Tertiary Prevention - Rehabilitation and Reducing Disability (1 mark)

1. Rehabilitation: Physiotherapy for stroke, hip fracture recovery; occupational therapy
2. Joint replacement: Hip/knee arthroplasty for osteoarthritis
3. Long-term care facilities: Nursing homes, old age homes (government + NGO-run)
4. Palliative care: Pain management, end-of-life care
5. Social support:
   • Elder Line 14567 (national helpline for elderly in India)
   • Day care centres for elderly
   • Rajiv Gandhi National Fellowship, Indira Gandhi National Old Age Pension Scheme (IGNOAPS)
6. Maintenance medication: Long-term management of hypertension, DM, cardiac diseases to prevent complications
7. Assistive devices: Wheelchairs, walking frames, hearing aids, spectacles

---

Q5. Adolescent Reproductive and Sexual Health (ARSH) Programme (5 Marks)

Background (0.5 marks)

• India has approximately 253 million adolescents (10-19 years) = largest adolescent population in the world
• Adolescent health is a national priority under RMNCH+A (Reproductive, Maternal, Newborn, Child, and Adolescent Health) strategy

Key Issues in Adolescent Health:

• Early marriage and early pregnancy (PCMA Act: 18 yrs girls, 21 yrs boys)
• Anaemia (56% of adolescent girls in India are anaemic - NFHS-5)
• Malnutrition and stunting
• RTI/STI and HIV
• Substance abuse; mental health; gender-based violence

---

Rashtriya Kishor Swasthya Karyakram (RKSK) 2014 (2 marks)

1. Nutrition - WIFS, deworming, obesity prevention
2. Sexual and Reproductive Health (SRH) - menstruation, contraception, STI, RTI
3. Non-communicable diseases - prevention of tobacco, obesity, hypertension
4. Mental health - counseling, suicide prevention, stress management
5. Substance misuse - tobacco, alcohol, drugs
6. Injuries and violence - road traffic injuries, gender-based violence

---

Specific Components and Services (2 marks)

1. Weekly Iron and Folic Acid Supplementation (WIFS)

• Every Monday (Mangalwar) in schools
• IFA tablet (100 mg elemental iron + 0.5 mg folic acid) - Blue tablet for adolescents
• Targets: All adolescent girls and boys in government schools classes 6-12
• Out-of-school girls: Distributed through ASHA/AWW
• Goal: Reduce anaemia prevalence

2. Biannual Deworming

• Albendazole 400 mg twice yearly (February and August - National Deworming Day)
• Reduces helminthic burden which contributes to anaemia and malnutrition

3. Adolescent-Friendly Health Clinics (AFHCs)

• Located at CHC level (and above)
• Confidential, non-judgmental, youth-friendly services
• Services: counseling (SRH, mental health, nutrition), RTI/STI management, contraceptive services, referral
• Timing: Separate hours or space for adolescents
• Staffed by trained counselors

4. Peer Educators

• Trained adolescents (peer educators) deliver health and life skills education to their peers
• Topics: menstruation, hygiene, safe sex, HIV, substance abuse

5. Kishori Shakti Yojana (KSY)

• Life skills and vocational training for adolescent girls (10-19 years)
• Delivered through Anganwadi Workers (AWW)
• Focuses on nutrition, health, hygiene education

6. School Health Programme (RBSK)

• Rashtriya Bal Swasthya Karyakram: screens 0-18 year olds for 4Ds: Defects at birth, Diseases, Deficiencies, Developmental delays

7. Menstrual Hygiene Scheme

• Subsidized sanitary napkins through ASHA (Suvidha brand) for adolescent girls in rural areas

---

Outcome Indicators (0.5 marks)

• Prevalence of anaemia in adolescent girls and boys
• Age at marriage
• Proportion using contraception
• RTI/STI prevalence
• Attendance at AFHCs

---

Q6. Any Four Side Effects of IUCD (5 Marks)

---

Side Effect 1: Menstrual Disturbances (Most Common) - 1.5 marks

• Menorrhagia (increased menstrual blood loss): Copper IUCDs increase menstrual flow by 20-50%. Due to:
  • Prostaglandin release (copper acts as local inflammatory agent)
  • Increased fibrinolysis
  • Endometrial vascular changes
• Dysmenorrhoea (painful periods): More intense uterine contractions; prostaglandin-mediated
• Metrorrhagia (inter-menstrual spotting)
• Oligomenorrhoea/amenorrhoea: Seen with LNG-IUS (Mirena) - NOT copper IUCD
• Consequence: Can lead to iron-deficiency anaemia with chronic heavy bleeding
• Management: Mefenamic acid for dysmenorrhoea; iron supplementation; if severe, consider removal

---

Side Effect 2: Pain and Discomfort - 1 mark

• Insertion pain: Cervical dilation and uterine sounding causes pain; especially in nulliparous women
• Pelvic cramping: In first few weeks to months after insertion; as uterus adjusts to foreign body
• Backache: Lower back pain associated with cramping
• Expulsive pain: Strong cramping during expulsion attempts
• Management: NSAIDs (Ibuprofen, Mefenamic acid) 30 minutes before insertion; local anaesthesia

---

Side Effect 3: Pelvic Inflammatory Disease (PID) and Infection - 1.5 marks

• Mechanism: During IUCD insertion, cervical barrier is breached; bacteria can be carried from cervix/vagina into uterus
• Risk period: Highest in first 20 days after insertion (procedure-related)
• After 20 days, risk is related to sexually transmitted infections (STIs)
• Types: Endometritis, salpingitis, oophoritis, tubo-ovarian abscess
• Increased risk with: Multiple sexual partners, pre-existing STI/RTI, insertion during active infection
• Consequences:
  • Infertility (tubal damage)
  • Ectopic pregnancy (damaged tubes)
  • Chronic pelvic pain
• Prevention: Screen for STIs before insertion; maintain aseptic technique; no insertion if active infection present
• Management: Antibiotics; if severe, remove IUCD and treat

---

Side Effect 4: Expulsion - 1 mark

• Spontaneous expulsion: IUCD is expelled from the uterus without the woman knowing
• Rate: 5-10% in first year; subsequent years much lower
• Higher risk in:
  • Young, nulliparous women (small uterus)
  • Immediately post-partum insertion
  • Insertion during menstruation (some evidence)
  • Uterine anomalies (fibroids, bicornuate uterus)
• Problem: Silent/unnoticed expulsion leads to unintended pregnancy
• Detection: Women taught to check for IUCD threads monthly (after menstruation); thread absent = expulsion
• Management: Repeat insertion after confirming not pregnant

---

Additional Notable Side Effects (for completeness):

• Ectopic pregnancy: If IUCD fails, pregnancy is 5-10x more likely to be ectopic (tubal)
• Uterine perforation: 1 in 1000 insertions; operator-dependent complication
• Missing threads: Thread retraction into uterus (not same as expulsion); requires ultrasound
• Actinomyces: Long-term IUCD users may have Actinomyces on Pap smear (usually asymptomatic)

---

Q7. MTP Act 1971 - Conditions, Persons Who Can Perform, Setting (5 Marks)

Introduction (0.5 marks)

• Reduce maternal mortality and morbidity from unsafe, illegal abortions
• Provide a legal framework for termination of pregnancy under specified conditions
• Prior to this act, abortion was a criminal offence under IPC Section 312

1. The conditions under which pregnancy can be terminated
2. The persons who can perform it
3. The place where it can be done

---

1. Conditions Under Which Pregnancy Can Be Terminated (2 marks)

• Written consent of guardian required for women <18 years and for lunatics (even if >18 years)
• Woman's own consent is sufficient for adults (no spousal consent required)

---

2. Persons Who Can Perform MTP (1.5 marks)

---

3. Place Where MTP Can Be Done (1 mark)

• Government hospital established or maintained by Government, OR
• A place approved for the purpose by the Government (approved/certified nursing homes/hospitals)
• All abortion services must be maintained in strict confidence
• The name of the abortion seeker is kept confidential (treated as a personal matter)

---

MTP (Amendment) Act 2021 - Key Changes (0.5 marks)

1. Upper limit: 20 weeks → 24 weeks for special categories (above)
2. For fetal abnormalities: No upper gestational limit; requires Medical Board approval
3. Strengthened confidentiality provisions
4. Removed requirement for approval board for first-trimester abortions

---

Q8. Indices to Assess Protein Quality and Quantity + Why Egg is Reference Protein (5 Marks)

---

Indices to Assess Protein Quantity (0.5 marks)

1. Total dietary protein intake (grams/day) vs. RDA
   • Adults: 0.8 g/kg/day; lactating women: 1.2 g/kg/day; growing children: higher
2. 24-hour dietary recall and food frequency questionnaire
3. Urinary nitrogen excretion: Nitrogen balance studies (Gold standard in research)
   • Nitrogen balance = N intake - N output
   • Positive balance: growth, pregnancy, recovery
   • Negative balance: starvation, illness, catabolic state

---

Indices to Assess Protein Quality (3.5 marks)

1. Biological Value (BV)

• Definition: The proportion of absorbed nitrogen that is retained in the body for maintenance and growth
• Formula: BV = (N retained / N absorbed) × 100
• Values: Egg = 100; Milk = 85-95; Meat = 75-80; Soy = 74; Wheat = 65; Maize = 60
• Limitation: Does not account for digestibility (measures only what is absorbed)

2. Net Protein Utilization (NPU)

• Definition: The proportion of dietary/ingested nitrogen that is retained
• Formula: NPU = (N retained / N intake) × 100 = BV × Digestibility coefficient
• Accounts for BOTH quality (BV) AND digestibility
• More comprehensive than BV alone
• Example: Egg NPU ≈ 94; Whole wheat NPU ≈ 67

3. Protein Efficiency Ratio (PER)

• Definition: Weight gain per unit of protein consumed in growing test animals (rats)
• Formula: PER = Weight gain (g) / Protein intake (g)
• Standard reference: Casein PER = 2.5
• Egg PER = 3.8; Soy PER = 2.1; Wheat PER = 1.5
• Limitation: Based on animal studies; may not directly apply to humans; only measures growth function

4. Chemical Score (Amino Acid Score)

• Definition: Compares the limiting essential amino acid of the test protein to the same amino acid in a reference protein (egg)
• Formula: Chemical Score = (mg of limiting EAA in 1g test protein / mg of same EAA in 1g reference protein) × 100
• Identifies the first limiting amino acid (the one most deficient)
• Example: Wheat is limited in lysine; Maize is limited in lysine and tryptophan

5. PDCAAS (Protein Digestibility-Corrected Amino Acid Score)

• Currently recommended by FAO/WHO/UNU (1991) as the standard for evaluating protein quality
• Formula: PDCAAS = Amino Acid Score × True fecal digestibility
• Scale: 0-1.0 (or expressed as %)
• Egg = 1.0 (maximum score); Casein = 1.0; Soy = 0.91; Beef = 0.92; Wheat = 0.40

6. DIAAS (Digestible Indispensable Amino Acid Score)

• Newer method (FAO 2013): More accurate than PDCAAS
• Uses ileal digestibility (not fecal) - more precise measure of absorption

---

Why Egg Protein is Taken as Reference Protein (1 mark)

1. BV = 100: 100% of absorbed egg nitrogen is retained - highest possible value
2. Contains ALL essential amino acids in exactly the right proportions required by the human body
3. Highly digestible: Digestibility coefficient ~97% (raw egg 51%; cooked egg 97%)
4. No anti-nutritional factors: Unlike plant proteins (phytates in cereals, tannins in pulses, trypsin inhibitors in legumes that reduce protein digestibility)
5. Consistent composition: Chemical composition of egg protein is well-characterized and reproducible
6. Chemical score = 100: When the amino acid profiles of other proteins are compared, egg's profile serves as the "ideal" standard

---

Q9. Health Programme Promotive Measures for Prevention of PEM (5 Marks)

Definition

• Marasmus: Energy deficiency predominant; wasting, skin and bones
• Kwashiorkor: Protein deficiency predominant; oedema, hair changes, skin lesions
• Marasmic-Kwashiorkor: Both

---

Health Programmes for PEM Prevention

1. ICDS - Integrated Child Development Services (Most Important) (1 mark)

• Launched: 1975; largest nutrition programme in the world
• Beneficiaries: Children 0-6 years, pregnant women, lactating mothers
• Delivered through: Anganwadi Centres (AWCs) by Anganwadi Workers (AWW)
• 6 services (SIX A's):
  1. Supplementary nutrition (SNP) - 500 kcal, 12-15g protein for children; 600 kcal for P/L women
  2. Immunization (through health department)
  3. Health check-up (growth monitoring by ANM)
  4. Referral services
  5. Pre-school non-formal education (3-6 years)
  6. Nutrition and health education for mothers

2. PM POSHAN (formerly Mid-Day Meal Scheme) (0.5 marks)

• Free cooked mid-day meal to children in government schools (Classes 1-8)
• Calorie norms: Primary (1-5): 450 kcal, 12g protein; Upper Primary (6-8): 700 kcal, 20g protein
• Goals: Improve nutritional status, increase school enrolment and attendance, reduce dropout

3. POSHAN Abhiyaan (National Nutrition Mission) - 2018 (0.5 marks)

• India's flagship nutrition programme
• Target: Reduce stunting and wasting by 2%/year; underweight by 2%/year; low birth weight by 2%/year
• Technology-driven: ICDS-CAS (Common Application Software) app for real-time monitoring
• Community mobilization: POSHAN Maah (September - Nutrition Month)
• Convergence of ICDS, PMMVY, NHM, Swachh Bharat

4. Pradhan Mantri Matru Vandana Yojana (PMMVY) (0.5 marks)

• Cash incentive of ₹5000 in instalments for first live birth
• Promotes early registration, ANC, institutional delivery, breastfeeding
• Indirectly improves maternal nutrition and birth weight

5. Vitamin A Supplementation Programme (0.5 marks)

• 2 lakh IU (200,000 IU) every 6 months for children 9 months to 5 years
• Under Universal Immunization Programme (UIP)
• Prevents Vitamin A deficiency (Bitot's spots, xerophthalmia, night blindness) and reduces mortality

6. Iron and Folic Acid (IFA) Supplementation (0.5 marks)

• Pregnant women: 100 mg iron + 500 mcg folic acid daily throughout pregnancy and 100 days postpartum (Large red tablet)
• Children 6-59 months: Biweekly syrup (20 mg iron)
• Adolescents (WIFS): Weekly IFA (Blue tablet, 100 mg iron) every Monday in schools
• Prevents iron-deficiency anaemia contributing to low birth weight and growth faltering

7. Management of SAM - Nutritional Rehabilitation Centres (NRCs) (0.5 marks)

• NRC: Inpatient management of Severe Acute Malnutrition (SAM) in children <5 years (WHO criteria: MUAC <11.5 cm or W/H <-3 SD)
• RUTF (Ready-to-Use Therapeutic Food): e.g., Plumpy'nut (peanut-based); 500 kcal/sachet; for community management of SAM
• F-75 and F-100 therapeutic milk formulae used in NRC inpatient protocol

8. Infant and Young Child Feeding (IYCF) / Breastfeeding Promotion (0.5 marks)

• Initiation of breastfeeding within 1 hour of birth
• Exclusive breastfeeding for 6 months (no water, no other food)
• Complementary feeding from 6 months while continuing breastfeeding till 2 years
• Promotion through ASHA, ANM, AWW
• Mother Absolute Affection (MAA) Programme: IEC campaign for breastfeeding

---

Q10. Pasteurization of Milk: Definition + Methods (5 Marks)

Definition (1 mark)

• Destroy all pathogenic organisms present in milk (including Mycobacterium tuberculosis - the most heat-resistant non-sporing pathogen and the index organism for pasteurization)
• Without significantly altering its composition, flavor, or nutritive value

---

Organisms Destroyed by Pasteurization

• Mycobacterium tuberculosis (bovine TB - index organism)
• Brucella species (Brucellosis/undulant fever)
• Salmonella species (Typhoid, food poisoning)
• Streptococcus (Scarlet fever, septic sore throat)
• Listeria monocytogenes
• Campylobacter jejuni
• E. coli O157:H7

---

Methods of Pasteurization (3 marks)

Method 1: Holder Method / LTLT (Low Temperature, Long Time) Method

• Oldest, simplest method
• Milk is heated in a holder/vat with agitation, then cooled rapidly to below 10°C
• Advantages: Simple equipment, suitable for small-scale production
• Disadvantages: Batch process - slow; not suitable for large-scale; risk of post-pasteurization contamination
• Suitable for rural dairies and small-scale operations

Method 2: Flash Method / HTST (High Temperature, Short Time) Method

• Modern, preferred commercial method
• Milk flows continuously through a plate heat exchanger - thin layers of milk heated and cooled rapidly
• Advantages: Large-scale; efficient; continuous; preserves nutritional quality better; less change in flavor
• Disadvantages: Expensive equipment; needs trained operators
• Used in most commercial dairies in India and worldwide

Method 3: UHT (Ultra High Temperature) Pasteurization

• Technically a sterilization process - kills all organisms including spores
• Milk is packed aseptically in Tetra Pak or similar cartons
• Shelf stable for 3-6 months without refrigeration (UHT milk)
• Advantages: Long shelf life, no cold chain needed; convenient for remote areas
• Disadvantages: Slight caramelized/cooked flavor; slightly reduced nutritional value (some heat-labile vitamins); expensive packaging

Method 4: In-Bottle Sterilization

• Complete destruction of all microorganisms; used for bottled milk sold without refrigeration
• Significantly alters flavor; reduces nutritional value
• Less common today

---

Tests to Confirm Adequacy of Pasteurization (1 mark)

1. Phosphatase Test (MOST IMPORTANT)

• Phosphatase enzyme (alkaline phosphatase) is naturally present in raw milk
• It is destroyed at pasteurization temperatures (inactivated at 62.8°C for 30 min)
• Negative phosphatase test = adequately pasteurized milk
• Positive phosphatase test = under-pasteurization OR post-pasteurization contamination with raw milk
• This is the standard test used to verify pasteurization

2. Turbidity Test (for sterilized milk)

• Serum proteins are denatured at sterilization temperatures
• No turbidity when heated = adequately sterilized

3. Coliform Count

• No coliforms should be present in adequately pasteurized milk

---

SHORT ANSWERS (2 Marks Each)

---

Q11. Dietary Principles of a Prudent Diet

1. Variety: Eat foods from all food groups - no single food is nutritionally complete
2. Calorie balance: Energy intake = energy expenditure; avoid obesity (BMI 18.5-22.9)
3. Reduce saturated and trans fats: <10% total calories from saturated fat; eliminate trans fats; use MUFA/PUFA
4. Increase dietary fibre: ≥25-30 g/day from whole grains, legumes, fruits, vegetables (reduces CVD, DM, colorectal cancer)
5. Reduce sodium (salt): <5 g/day (WHO); prevents hypertension
6. Reduce added/free sugars: <10% of total calories; prevents obesity and diabetes
7. Increase fruits and vegetables: ≥400 g/day (5 portions/day); source of antioxidants, phytochemicals, fibre
8. Limit red and processed meat: >500 g/week of red meat increases colorectal cancer risk
9. Adequate protein: 0.8-1.0 g/kg/day from diverse sources (legumes, fish, poultry)
10. Moderate alcohol: Ideally none; max 1 unit/day women, 2 units/day men if consumed

---

Q12. Rule of Halves

All hypertensives in community
        ↓ Only HALF are diagnosed (50%)
Of those diagnosed
        ↓ Only HALF are on treatment (50% of 50% = 25%)
Of those on treatment
        ↓ Only HALF are adequately controlled (50% of 25% = 12.5%)

• Highlights the enormous gap between disease burden and actual management at each stage
• Points to system failures in: screening/detection, treatment initiation, and treatment adherence
• Also applies to: diabetes, epilepsy, mental illness, rheumatic fever
• Guides health system strengthening priorities

---

Q13. Epidemiological Determinants of Rheumatic Fever

Agent

• Group A beta-haemolytic Streptococcus (Streptococcus pyogenes) - pharyngeal infection only (NOT skin infection)

Host Factors

• Age: Peak 5-15 years; uncommon <3 years and rare >25 years
• Sex: Equal; girls slightly more susceptible to Sydenham's chorea
• Genetic susceptibility: HLA-DR4, HLA-DR2 associated; familial clustering
• Previous RF: Most important risk factor for recurrence; each attack damages heart further
• Nutritional status: Malnutrition increases susceptibility

Environmental Factors

• Overcrowding: Facilitates streptococcal droplet spread (schools, military barracks)
• Poor housing: Overcrowded slums, inadequate ventilation
• Socioeconomic status: Low SES = highest incidence
• Climate: Cold and wet weather increases pharyngeal streptococcal infections; seasonal peaks in winter/spring
• Urbanization: Dense urban populations increase transmission

Epidemiology in India

• Prevalence: ~1% of school-age children have RHD
• Leading cause of acquired heart disease in children and young adults in India
• Global decline in developed countries due to improved living conditions and penicillin treatment

---

Q14. PERT

• Project management and scheduling tool; developed by US Navy (1958) for Polaris submarine missile project
• Used in health programme planning and management

1. Network diagram (PERT chart): Activities represented as nodes; arrows show sequence and dependencies
2. Three time estimates per activity:
   • O = Optimistic time (best case)
   • M = Most likely time (realistic)
   • P = Pessimistic time (worst case)
   • Expected Time (Te) = (O + 4M + P) / 6 (weighted average)
3. Critical Path: The longest path through the network = minimum time to complete project; activities on critical path have zero slack
4. Slack/Float: Allowable delay in non-critical activities without delaying project completion

---

Q15. Approaches in Health Education

By Target Group:

1. Individual approach: One-to-one counseling; most effective for behaviour change; used in clinical settings, home visits, antenatal consultations
2. Group approach: Group discussions, lectures, demonstrations, role plays; used in school health, community groups, OPD health talks
3. Mass/Community approach: Mass media - TV, radio, newspapers, social media; posters, hoardings; reaches large populations but low interaction and feedback

By Communication Method:

1. Direct (face-to-face): Highest impact; two-way communication; immediate feedback
2. Indirect (mediated): Print media, electronic media, digital media

By Sensory Channel:

1. Visual methods: Posters, flashcards, films, demonstrations, charts, flannel graphs
2. Auditory methods: Radio, talks, songs, announcements
3. Audiovisual (combined): TV, documentary films, street plays (Nukkad Natak), drama, puppet shows

---

Q16. Objectives of PNC (Postnatal Care)

1. Prevent and detect maternal complications: PPH (postpartum haemorrhage), puerperal sepsis, eclampsia, secondary PPH, anaemia
2. Promote and support breastfeeding: Initiation within 1 hour of birth; exclusive breastfeeding for 6 months; correct attachment and positioning
3. Newborn care: Warmth (kangaroo mother care for LBW), cord care, eye care, Vitamin K prophylaxis
4. Immunization of newborn: BCG, OPV-0, Hepatitis B (birth dose) - within 24 hours
5. Nutritional support: Continuation of IFA supplementation for 180 days postpartum; calcium supplementation
6. Family planning counseling: Discuss contraceptive options (IUCD insertion at 48 hours post-delivery or after 6 weeks, LAM, POP)
7. Detect and manage postnatal mental health: Postnatal depression screening (Edinburgh Postnatal Depression Scale)
8. Health education: Personal hygiene, nutrition, danger signs (excessive bleeding, foul-smelling discharge, fever, fits)
9. Registration and follow-up: Register newborn; schedule immunization visits

---

Q17. Any 6 Job Responsibilities of Female Health Worker (ANM)

1. Maternal Health / Antenatal Care (ANC):
   • Registration of pregnant women within first trimester
   • 4 ANC check-ups (blood pressure, weight, fundal height, fetal heart sounds)
   • TT immunization (2 doses); IFA supplementation distribution; Calcium tablets
   • Health education on diet, danger signs, institutional delivery
2. Intranatal Care (Delivery):
   • Conducting normal deliveries with clean/safe delivery practices
   • Identifying obstetric emergencies and timely referral
   • Immediate newborn care: drying, warming, cord cutting, resuscitation
3. Postnatal Care (PNC):
   • Home visits at 24-48 hours, 7 days, and 42 days postpartum
   • Promotion of exclusive breastfeeding
   • Newborn care: temperature, cord care, feeding
   • Maternal recovery monitoring
4. Child Health and Immunization:
   • Conducting immunization sessions under UIP (BCG, OPV, DPT, Measles-Rubella, Hepatitis B, Pentavalent)
   • Growth monitoring (weighing children monthly at sub-centre/AWC)
   • Vitamin A supplementation (every 6 months, 9 months-5 years)
   • Management of common childhood illnesses (ORS for diarrhoea, referral)
5. Family Planning Services:
   • Providing oral contraceptive pills (Mala-N, Mala-D), condoms
   • IUCD insertion (after training)
   • Counseling couples on spacing and limiting methods
   • Motivating eligible couples; maintaining family planning records
   • Reporting acceptance rates
6. Disease Surveillance and Public Health:
   • Collection of blood smears for malaria diagnosis and treatment (DOTS for malaria)
   • Leprosy case detection; referral for MDT
   • Reporting notifiable diseases to MO-PHC
   • Health education for prevention of communicable diseases
   • Safe drinking water and sanitation promotion
   • School health visits (inspection of children)

---

Q18. Triage

Colour-Coded Triage System:

Triage Systems:

• START (Simple Triage and Rapid Treatment): Used in mass casualty; assess: Respirations, Perfusion, Mental status - takes <30 seconds per patient
• SALT (Sort, Assess, Life-saving interventions, Treatment/Transport): US standard for mass casualty
• JumpSTART: Paediatric version of START
• CIAMPEDS: For paediatric triage in ED
• Manchester Triage System (MTS): Used in emergency departments

---

Q19. Dane Particles

• Described by: D.S. Dane in 1970 - hence the name
• Size: 42 nm in diameter (largest of the hepatitis viruses)
• Classification: Hepadnavirus; partially double-stranded circular DNA virus

Structure of Dane Particle:

Outer envelope (coat):
  - Contains HBsAg (Hepatitis B Surface Antigen)
  - Previously called "Australia Antigen" (discovered by Blumberg, 1965 - Nobel Prize)

Inner core (nucleocapsid):
  - HBcAg (Hepatitis B Core Antigen) - not detectable in serum
  - HBeAg (Hepatitis B e Antigen) - secreted into blood; marker of high infectivity
  - Partially double-stranded circular DNA (~3.2 kb)
  - DNA polymerase (with reverse transcriptase activity)

Other Particles Seen in HBV Infection:

• The 20 nm particles and filaments vastly outnumber Dane particles in blood (10,000:1)

Clinical Significance:

• Dane particles = infective virus = marker of active viral replication
• HBeAg positivity in blood correlates with high Dane particle count = high infectivity
• HBsAg in blood = standard screening test for HBV infection (detectable from 1-6 weeks post-exposure)
• Basis for vaccine: HBsAg from surface envelope = immunogenic; recombinant HBsAg = Hepatitis B vaccine

---

Q20. WHO (World Health Organization)

WHO Definition of Health (1948):

"Health is a state of complete physical, mental and social well-being and not merely the absence of disease or infirmity."

Organizational Structure:

1. World Health Assembly (WHA): Supreme governing body; meets annually in May; all 194 member states represented; sets policies and approves budget
2. Executive Board: 34 members elected for 3 years; implements WHA decisions; meets twice yearly
3. Secretariat: Technical and administrative arm; headed by Director-General

Six Regional Offices:

Key Functions of WHO:

1. Setting norms and standards for health (ICD-10, drug quality standards)
2. Providing technical assistance to member countries
3. Monitoring global health situations (disease surveillance, EWARN)
4. Coordinating research
5. Developing and promoting health policies and guidelines
6. Emergency response: Outbreaks, pandemics, disasters
7. Training and capacity building

Key Milestones:

• IHR (International Health Regulations) 2005: Legal framework for international disease control
• FCTC (Framework Convention on Tobacco Control): First international public health treaty
• COVID-19: Declared PHEIC (Public Health Emergency of International Concern) January 30, 2020; Pandemic March 11, 2020
• Smallpox eradication: Certified 1980 - WHO's greatest achievement
• SDGs: WHO aligned with UN Sustainable Development Goals (SDG 3: Good Health and Well-being)

---

---

Chronic Lung Disease: Detailed History Taking + Differential Diagnosis

---

PART 1: HISTORY TAKING IN CHRONIC LUNG DISEASE

---

STEP 1 — PRESENTING COMPLAINT

1. Dyspnoea (breathlessness)
2. Cough
3. Sputum production
4. Wheeze

---

STEP 2 — HISTORY OF PRESENTING ILLNESS

---

A. DYSPNOEA

• Sudden onset: pneumothorax, pulmonary embolism, acute exacerbation
• Weeks-months: pleural effusion, pneumonia, lung cancer
• Months-years (insidious): COPD, IPF, pulmonary hypertension, bronchiectasis

• Episodic and reversible with symptom-free intervals → Asthma
• Diurnal variation (worse at night/early morning) → Asthma
• Persistent and progressive → COPD, IPF, pulmonary hypertension
• Worse on lying flat (orthopnoea) → Heart failure, large pleural effusion
• Worse on standing (platypnoea) → Hepatopulmonary syndrome
• Worse in specific environment → Occupational asthma or hypersensitivity pneumonitis

• Cold air, exercise, allergens, NSAIDs → Asthma
• Exertion only (no episodic quality) → COPD, IPF, heart failure
• Syncope on exertion → Pulmonary arterial hypertension (RED FLAG)

• What specific activities are now impossible that were previously possible?
• Previous exercise tolerance vs. current (quantify: floors climbed, distance walked)

---

B. COUGH

• Acute (<3 weeks): infection, aspiration
• Subacute (3-8 weeks): post-infective, pertussis
• Chronic (>8 weeks): COPD, asthma, bronchiectasis, ILD, lung cancer, ACE inhibitor cough, UACS (upper airway cough syndrome/post-nasal drip), GERD

• Dry, non-productive, irritating: ILD/IPF (characteristic dry hacking cough), asthma (can be dry), ACE inhibitor cough, lung cancer
• Productive (mucoid, white/clear): COPD (chronic bronchitis), asthma (mucoid plugs)
• Productive (purulent, large volume): Bronchiectasis, COPD exacerbation, lung abscess
• Metallic/brassy cough: Tracheal compression by tumour or mediastinal mass
• Bovine cough (no explosive element): Left recurrent laryngeal nerve palsy (Ortner's syndrome) - lung cancer, aortic aneurysm
• Barking/croupy: Upper airway

• Morning predominance with purulent sputum → Chronic bronchitis, bronchiectasis (postural drainage on waking)
• Nocturnal predominance → Asthma, heart failure, GERD, post-nasal drip
• After eating/lying down → GERD-induced cough, aspiration
• On exercise → Exercise-induced asthma
• Positional change → Bronchiectasis (increased on lying on one side)

• Better on weekends/holidays → Occupational asthma
• Seasonal variation → Allergic asthma (pollen seasons)
• Better away from home → Domestic allergen (house dust mite, pet dander)

• Blood-streaked sputum: chronic bronchitis, bronchiectasis
• Frank haemoptysis: lung cancer, TB, bronchiectasis, pulmonary embolism with infarction, vasculitis (GPA)
• Pink frothy sputum: acute pulmonary oedema
• Rust-coloured sputum: lobar pneumonia (pneumococcal)
• Massive haemoptysis (>200 mL/24 hrs): bronchiectasis, mycetoma, carcinoma, TB - EMERGENCY

---

C. SPUTUM

• Scant → COPD (simple chronic bronchitis), asthma
• Large volume (>30 mL/day) → Bronchiectasis, lung abscess ("mouthfuls of sputum")
• Quantify in teaspoons or "egg-cup" per day

• Foul-smelling/fetid sputum → Lung abscess, anaerobic infection, bronchiectasis (secondary infection)

---

D. WHEEZE

• Expiratory wheeze: Lower airways obstruction - asthma, COPD
• Inspiratory wheeze (stridor): Upper airway obstruction - foreign body, tracheal stenosis, goitre, laryngeal tumour
• Fixed/monophonic wheeze: Single large airway obstruction (carcinoma, foreign body) - same pitch regardless of effort
• Variable/polyphonic wheeze: Multiple airways - asthma, COPD
• Cardiac wheeze: Pulmonary oedema ("cardiac asthma") - bilateral, nocturnal

---

E. CHEST PAIN

• Pleuritic (sharp, worse on inspiration, coughing): Pleuritis, pleuropneumonia, pulmonary embolism (PE), pneumothorax, mesothelioma
• Central chest tightness: Asthma, cardiac ischaemia
• Dull central ache: Mediastinal involvement (cancer, lymphoma)
• Chest wall pain (worse on palpation): Musculoskeletal, rib fracture, Tietze's syndrome

---

STEP 3 — SMOKING HISTORY (MANDATORY IN EVERY PATIENT)

• Current smoker / Ex-smoker / Never-smoker?
• Type: Cigarettes, cigars, pipe, cannabis (joints), hookah/shisha, e-cigarettes (vaping)
• If current: How many cigarettes per day?
• Age started smoking?
• If ex-smoker: Age stopped? Reason for stopping?

Pack-years = (Number of cigarettes per day / 20) × Years smoked Example: 20 cigarettes/day for 30 years = 30 pack-years

• COPD uncommon with <10 pack-years → consider alternative diagnosis if <10 pack-years
• Lung cancer risk significantly elevated >20 pack-years
• Smoking cessation benefit: risk starts declining from first day of cessation

• Exposure at home (spouse smoker)?
• Exposure at workplace?
• Childhood exposure to parental smoking (affects lung development)

---

STEP 4 — OCCUPATIONAL AND ENVIRONMENTAL HISTORY (LIFELONG)

• List every job ever held (from first job to present)
• Duration in each role
• Nature of exposure in each job
• Interval between exposure and onset of symptoms
• Does improvement occur on weekends, holidays, away from workplace?

• Damp walls, visible mould (hypersensitivity pneumonitis)
• Unchanged air-conditioning/ventilation filters
• Hot tub, water leaks, humidifiers
• Pets (especially birds - budgies, pigeons, parrots)
• Feather pillows/duvets (Bird Fancier's Lung)
• Cooking fuel: biomass fuel (wood, dung, crop residue) - major cause of COPD in non-smoking women in South Asia/India

---

STEP 5 — DRUG AND MEDICATION HISTORY

• ACE inhibitors (captopril, enalapril, ramipril) - dry persistent cough in up to 15%; class effect; resolves with switch to ARB

• Beta-blockers (including eye drops timolol) - can cause bronchospasm in asthma/COPD
• NSAIDs/Aspirin - Samter's triad (aspirin-exacerbated respiratory disease) in ~10% of asthmatics

• Fenfluramine, dexfenfluramine (withdrawn)
• Methamphetamine, cocaine

• Cannabis - chronic bronchitis, COPD-like changes
• Cocaine (crack cocaine) - pulmonary haemorrhage, BOOP
• Intravenous drugs - septic emboli, aspiration, talc granulomatosis

---

STEP 6 — PAST MEDICAL HISTORY

• Childhood asthma (often predicts adult asthma; may have remitted then recurred)
• Recurrent chest infections in childhood → bronchiectasis (Roberts/Williams criteria)
• Whooping cough (pertussis) → bronchiectasis
• Measles pneumonia → bronchiectasis
• TB in childhood → post-TB bronchiectasis, fibrocavitary scarring

• Previous episodes of wheezing, breathlessness
• Prior diagnosis: asthma, COPD, TB, bronchiectasis, sarcoidosis
• Previous hospitalizations for chest disease (frequency, ICU admissions, need for ventilation)
• Intubation/mechanical ventilation → indicates previous life-threatening episode (severe asthma, COPD)
• Previous spirometry results and trend over time
• Previous chest X-rays or CT scans (obtain for comparison)

---

STEP 7 — FAMILY HISTORY

• COPD onset <45 years
• Never-smoker or minimal smoker with COPD
• Predominantly lower lobe emphysema
• Family history of emphysema/liver disease

---

STEP 8 — SOCIAL HISTORY

• Heavy use → aspiration pneumonia (impaired airway reflexes), Klebsiella pneumonia, TB, lung abscess
• Malnutrition with alcohol → immune deficiency

• Damp, mouldy housing → HP, respiratory infections, asthma exacerbations
• Overcrowding → TB transmission
• Type of cooking fuel: biomass/solid fuel (wood, charcoal, dung) = major risk factor for COPD in non-smoking women (especially rural India, Africa)

• Birds (budgerigar, pigeon, parrot, canary) → Bird Fancier's Lung (HP)
• Cats/dogs → allergen sensitization, asthma exacerbations
• Horses → HP (equine antigens)

• Pigeon racing/keeping → Bird Fancier's Lung
• Mushroom growing, cheese making → HP
• Hot tub/sauna use → HP (non-tuberculous mycobacteria)

• TB endemic areas (Southeast Asia, Sub-Saharan Africa, Eastern Europe)
• Histoplasmosis - Ohio River Valley, Central America (bats, bird droppings)
• Coccidioidomycosis - Southwest USA, Central America
• Paragonimiasis - East Asia (lung fluke from crustaceans)
• Echinococcosis (hydatid disease) - Middle East, Mediterranean, pastoralists

• Quantify precisely: Can the patient walk on flat? Climb stairs? How many flights?
• Recent change in exercise tolerance?

• Unintentional weight loss + cough → lung cancer, TB
• Weight gain/fluid retention → cor pulmonale from COPD
• Cachexia → advanced COPD, malignancy

---

STEP 9 — SYSTEMS REVIEW

---

STEP 10 — AGE AND GENDER CLUES

---

---

PART 2: DIFFERENTIAL DIAGNOSIS OF CHRONIC LUNG DISEASE

---

DIFFERENTIAL DIAGNOSIS FRAMEWORK

Chronic Dyspnoea + Cough + ± Sputum
         ↓
Is it OBSTRUCTIVE or RESTRICTIVE or VASCULAR?
         ↓
FEV1/FVC ratio:
  <0.70 post-bronchodilator → OBSTRUCTIVE
  Normal FEV1/FVC but ↓TLC → RESTRICTIVE  
  Normal spirometry but ↑PAP → VASCULAR

---

GROUP 1 — OBSTRUCTIVE LUNG DISEASES

---

1. COPD (Chronic Obstructive Pulmonary Disease)

• Chronic productive cough for ≥3 months/year for ≥2 consecutive years (chronic bronchitis definition)
• Progressive exertional dyspnoea, worse in winter
• Reduced exercise tolerance over years
• Frequent exacerbations (increased dyspnoea + increased sputum purulence/volume)
• NO symptom-free intervals between episodes
• Smoking history is the dominant risk factor

• Onset after 40 (vs. childhood/young adult in asthma)
• No episodic quality - continuous symptoms
• Airflow obstruction INCOMPLETELY reversible post-bronchodilator (FEV1/FVC <0.70 persists)
• No atopy
• DLCO reduced (especially in emphysema-predominant)

• Post-bronchodilator FEV1/FVC < 0.70 = confirms obstruction
• GOLD 1 (Mild): FEV1 ≥80% predicted
• GOLD 2 (Moderate): 50% ≤ FEV1 <80%
• GOLD 3 (Severe): 30% ≤ FEV1 <50%
• GOLD 4 (Very Severe): FEV1 <30%

• Hyperinflation (flattened hemidiaphragms on lateral view)
• Increased retrosternal airspace (>4.5 cm on lateral)
• Hyperlucency, diminished peripheral vascular markings
• Upper lobe bullae (nearly diagnostic when present)

• Emphysema-predominant ("Pink Puffer"): Thin, barrel-chested, pursed lip breathing, no cyanosis, minimal cough
• Chronic bronchitis-predominant ("Blue Bloater"): Obese, cyanosed, oedematous, productive cough, cor pulmonale

---

2. Asthma

• Episodic dyspnoea, wheeze, chest tightness, cough
• Symptom-free intervals between episodes (distinguishes from COPD)
• Diurnal variation: Worse at night and early morning (3-4 AM - circadian cortisol trough)
• Identifiable triggers:
  • Allergens: house dust mite, pet dander, pollen, moulds
  • Exercise (especially cold air exercise)
  • Cold air, fog, strong smells
  • NSAIDs/aspirin (Samter's triad - nasal polyps + aspirin sensitivity + asthma)
  • Beta-blockers (even topical)
  • Respiratory infections (viral most common trigger)
  • Emotional stress
  • Occupational exposures (isocyanates = most common occupational cause)
• Personal/family history of atopy (eczema, allergic rhinitis) - atopic triad
• Good response to bronchodilators (complete reversibility)

• Obstructive pattern (FEV1/FVC <0.70) during symptoms
• ≥12% AND ≥200 mL improvement in FEV1 post-bronchodilator = confirms reversibility
• Normal spirometry between attacks (unlike COPD)
• Methacholine challenge test: Positive (PC20 <8 mg/mL) = confirms bronchial hyperreactivity

---

3. Bronchiectasis

• Chronic productive cough - key feature
• Large volumes of purulent sputum (may be >100 mL/day) - the hallmark
• Three-layer sputum (Quincke's layers): purulent base, watery middle, frothy top
• Postural drainage: sputum production worse on waking and on lying on a particular side
• Recurrent chest infections requiring repeated antibiotics (≥3 courses/year)
• Haemoptysis (blood-streaked to massive haemoptysis in advanced disease)
• Progression over many years

• Radiology: Chest CT - signet-ring sign (airway diameter ≥1.5× adjacent vessel); "tram tracks" on plain film
• Clinical criteria: cough most days + sputum most days + history of exacerbations (≥2 of 3 required)
• Sputum culture: Pseudomonas aeruginosa = marker of severe, established disease; H. influenzae = earlier/milder; S. aureus = consider CF

---

4. Obliterative Bronchiolitis (Constrictive Bronchiolitis)

• Progressive dyspnoea and dry cough
• Following: lung/BMT transplant (bronchiolitis obliterans syndrome), toxic fume inhalation, connective tissue disease, post-infectious (adenovirus, mycoplasma)
• FEV1 decline post-transplant = cardinal sign of BOS (Bronchiolitis Obliterans Syndrome)
• CT: mosaic attenuation, air trapping on expiratory views; tree-in-bud

---

GROUP 2 — RESTRICTIVE LUNG DISEASES (ILD)

---

5. Idiopathic Pulmonary Fibrosis (IPF)

• Insidious onset of progressive exertional dyspnoea (over months-years)
• Dry, non-productive, hacking cough - frustrating, persistent
• No identifiable cause (by definition - "idiopathic")
• Age >60 years (rare <50)
• Male predominance
• Clubbing (bilateral; 25-50% of patients)
• Fine, bi-basal, Velcro-like (end-inspiratory) crackles on auscultation
• No wheeze, no fever, no haematuria

• No significant occupational exposure
• No CTD features (distinguishes from CTD-ILD)
• No drug exposure
• No environmental exposure

---

6. Connective Tissue Disease-ILD (CTD-ILD)

• RA: morning stiffness, symmetrical small joint arthritis, nodules, hand deformity
• Systemic sclerosis: Raynaud's, skin tightening (sclerodactyly), telangiectasia, dysphagia, calcinosis
• Polymyositis/Dermatomyositis: Proximal muscle weakness, Gottron's papules, heliotrope rash, "mechanic's hands"
• Sjögren's: Dry eyes (keratoconjunctivitis sicca), dry mouth (xerostomia)
• SLE: Malar rash, photosensitivity, serositis, joint pain, haematuria
• MCTD: Features of several CTDs; anti-U1 RNP antibodies

• SSc → NSIP > UIP
• RA → UIP, OP, DIP
• PM/DM → NSIP, DAD (acute exacerbations)
• Sjögren's → LIP (Lymphoid IP)
• SLE → shrinking lung, pleuritis, DAH

---

7. Hypersensitivity Pneumonitis (HP) / Extrinsic Allergic Alveolitis (EAA)

• Farmer's Lung: Exposure to mouldy hay/grain; thermophilic actinomycetes
• Bird Fancier's Lung: Exposure to birds (pigeons most common in UK/India); budgerigars, parrots
• Hot Tub Lung: Hot tub use; non-tuberculous mycobacteria
• Malt Worker's Lung: Aspergillus clavatus in malt
• Mushroom Worker's Lung: Thermophilic actinomycetes

• Fever, chills, myalgia, dyspnoea 4-8 hours after exposure (flu-like illness)
• Resolves with removal from exposure
• Often misdiagnosed as recurrent "flu" or "pneumonia"

• Insidious progressive dyspnoea + dry cough
• Weight loss
• No clear episodic relationship with exposure (ongoing low-level exposure)
• Can resemble IPF clinically and on HRCT
• Key: Detailed exposure history distinguishes HP from IPF

---

8. Sarcoidosis

• Constitutional symptoms: fever, night sweats, fatigue, weight loss
• Lofgren's syndrome (acute onset): Erythema nodosum + bilateral hilar lymphadenopathy + polyarthritis + fever = good prognosis
• Respiratory: Dyspnoea, dry cough (may be absent)
• Eye: Uveitis (anterior > posterior; red painful eye; floaters)
• Skin: Lupus pernio (violaceous plaques on nose, cheeks = chronic sarcoid), erythema nodosum (acute)
• CNS: Facial nerve palsy, seizures, meningitis
• Cardiac: Heart block, ventricular arrhythmia (sudden death)
• Hypercalcaemia: Nephrocalcinosis, nephrolithiasis, polydipsia
• Parotid enlargement (Heerfordt's syndrome: parotitis + uveitis + facial palsy)
• Hypergammaglobulinaemia (elevated serum ACE)

• Stage 0: Normal CXR
• Stage 1: Bilateral hilar lymphadenopathy (BHL) only
• Stage 2: BHL + parenchymal infiltrates
• Stage 3: Parenchymal infiltrates, no BHL
• Stage 4: Pulmonary fibrosis

---

9. Occupational ILD - Pneumoconioses

• Quarrying, sandblasting, tunnelling, mining
• Nodular fibrosis; upper lobe predominance
• "Eggshell calcification" of hilar nodes
• Risk of TB (silicotuberculosis - silica impairs macrophage function)
• Accelerated silicosis: Heavy exposure → rapid progression over months

• Asbestos exposure (shipyard, insulation, construction, brake liners)
• Latency >20 years from first exposure
• Progressive exertional dyspnoea + dry cough
• Bi-basal crackles; clubbing
• Associated with: mesothelioma, carcinoma bronchus, pleural plaques, pleural effusion
• HRCT: sub-pleural lines, honeycombing (lower lobes); pleural plaques with calcification

• Simple CWP: Small rounded opacities (0-5 mm); may be asymptomatic
• Progressive Massive Fibrosis (PMF): Large opacities >1 cm; dyspnoea + airflow obstruction

---

GROUP 3 — PULMONARY VASCULAR DISEASES

---

10. Pulmonary Arterial Hypertension (PAH)

• Progressive exertional dyspnoea - earliest and most consistent symptom
• Syncope or pre-syncope on exertion = RED FLAG for PAH; indicates inability to increase cardiac output with exercise
• Exertional chest pain (anginal due to RV ischaemia)
• Fatigue, lethargy
• Palpitations (RV distension → arrhythmias)
• Peripheral oedema (signs of right heart failure)
• Haemoptysis (uncommon; in situ pulmonary artery thrombosis)
• Associated conditions:
  • Connective tissue disease (SSc-PAH = worst prognosis)
  • HIV infection
  • Portal hypertension/chronic liver disease (porto-pulmonary hypertension)
  • Congenital heart disease (Eisenmenger's syndrome)
  • Drug history (fenfluramine, methamphetamine)
  • Family history (BMPR2 mutation)

---

GROUP 4 — CHRONIC AIRWAY INFECTIONS

---

11. Pulmonary Tuberculosis (TB)

• Chronic cough >3 weeks (WHO threshold for TB suspect)
• Constitutional symptoms: fever (classically low-grade, evening rise), night sweats, anorexia, weight loss (TB = "consumption")
• Haemoptysis (may be massive in cavitatory TB or Rasmussen's aneurysm)
• Contact history: Known TB contact, household member with TB
• High-risk exposures: Travel to endemic areas; HIV positive; prison; homeless; healthcare worker
• Immunosuppression: HIV (especially CD4 <200 = atypical presentations), steroids, anti-TNF therapy, diabetes mellitus, malnutrition
• Previous TB treatment history (drug resistance risk)
• BCG vaccination status

---

DIFFERENTIAL DIAGNOSIS TABLE — SUMMARY

---

KEY DIAGNOSTIC CLUES FROM HISTORY — RAPID REFERENCE

---

• Harrison's Principles of Internal Medicine 22E (2025) - Bronchiectasis chapter
• Symptom to Diagnosis: An Evidence-Based Guide, 4th Edition - COPD/Bronchiectasis differential
• Goldman-Cecil Medicine - Chapter 80: Interstitial Lung Disease (History section)
• Fishman's Pulmonary Diseases and Disorders - COPD, Pulmonary Hypertension
• Murray & Nadel's Textbook of Respiratory Medicine - Bronchiectasis clinical features